Literature DB >> 7782605

D-2-hydroxyglutaric aciduria.

W L Nyhan1, G D Shelton, C Jakobs, B Holmes, C Bowe, C J Curry, C Vance, M Duran, L Sweetman.   

Abstract

Hydroxyglutaric aciduria is detected by gas chromatographic-mass spectrometric analysis, and the D and L forms are quantified by chemical ionization with deuterated internal standards. Patients have recently been described who accumulate the D form, and they appear to be quite different from those with the more common L form. Experience is reported with three patients and an animal model with D-2-hydroxyglutaric aciduria. The phenotype appears to include mental retardation, macrocephaly, hypotonia, seizures, and involuntary movements, although neurologic and systemic manifestations of the disorder varied considerably between individual patients, even within the same family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782605     DOI: 10.1177/088307389501000216

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  12 in total

1.  D-2-hydroxyglutaric aciduria: further clinical delineation.

Authors:  M S van der Knaap; C Jakobs; G F Hoffmann; M Duran; A C Muntau; S Schweitzer; R I Kelley; F Parrot-Roulaud; J Amiel; P De Lonlay; D Rabier; O Eeg-Olofsson
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  D-2-hydroxyglutaric aciduria: evidence of clinical and biochemical heterogeneity.

Authors:  L Wagner; G F Hoffmann; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 3.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

4.  D-2-Hydroxyglutaric aciduria in a patient with a severe clinical phenotype and unusual MRI findings.

Authors:  M Wajne; C R Vargas; C Funayama; A Fernandez; M L C Elias; S I Goodman; C Jakobs; M S van der Knaap
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

5.  Metaphyseal chondromatosis combined with D-2-hydroxyglutaric aciduria in four patients.

Authors:  Hye Jung Choo; Tae-Joon Cho; Junghan Song; George E Tiller; Sun Hee Lee; Gunbo Park; In Sook Lee; Ralph Lachman; Andrea Superti-Furga; Ok-Hwa Kim
Journal:  Skeletal Radiol       Date:  2012-05-26       Impact factor: 2.199

6.  D-2-Hydroxyglutaric aciduria with absence of corpus callosum and neonatal intracranial haemorrhage.

Authors:  X Wang; C Jakobs; E V Bawle
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

7.  Peripheral neuropathy in a patient with D-2-hydroxyglutaric aciduria.

Authors:  G Haliloglu; C M Temucin; K K Oguz; A Celiker; T Coskun; J O Sass; J Fischer; M Topcu
Journal:  J Inherit Metab Dis       Date:  2009-01-26       Impact factor: 4.982

Review 8.  Progress in understanding 2-hydroxyglutaric acidurias.

Authors:  Martijn Kranendijk; Eduard A Struys; Gajja S Salomons; Marjo S Van der Knaap; Cornelis Jakobs
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

9.  Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2.

Authors:  D Thirumal Kumar; L Jerushah Emerald; C George Priya Doss; P Sneha; R Siva; W Charles Emmanuel Jebaraj; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-07-09       Impact factor: 3.655

10.  Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.

Authors:  Luyuan Li; Ana C Paz; Breelyn A Wilky; Britt Johnson; Karina Galoian; Andrew Rosenberg; Guozhi Hu; Gabriel Tinoco; Olaf Bodamer; Jonathan C Trent
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.